Subtopic Deep Dive
Granuloma Annulare and Metabolic Disease
Research Guide
What is Granuloma Annulare and Metabolic Disease?
Granuloma annulare (GA) is an inflammatory granulomatous skin disease linked to metabolic disorders like type 2 diabetes and hyperlipidemia, presenting as annular dermal plaques in localized or generalized forms.
GA affects 0.1-0.4% of the population, with generalized forms associating more strongly with diabetes and dyslipidemia (Joshi and Duvic, 2021, 120 citations). Cohort studies confirm GA patients have 1.8-fold higher diabetes risk and 1.5-fold hyperlipidemia risk (Barbieri et al., 2021, 48 citations). Over 79% of diabetes patients show skin manifestations, including GA (Duff et al., 2015, 129 citations).
Why It Matters
GA serves as a cutaneous marker for undiagnosed diabetes and dyslipidemia, enabling early metabolic screening in dermatology clinics (Barbieri et al., 2021). In diabetes cohorts, GA prevalence reaches 2-5%, correlating with poor glycemic control and guiding holistic management (Duff et al., 2015; Mendes et al., 2017). Therapeutic responses in GA improve with lipid-lowering agents, linking skin pathology to systemic metabolic treatment (Joshi and Duvic, 2021). Population studies show GA predicts incident autoimmune disorders, expanding its prognostic value (Barbieri et al., 2021).
Key Research Challenges
Heterogeneous Clinical Subtypes
Localized GA responds to topical therapies, but generalized GA resists treatment and links more strongly to metabolic disease (Joshi and Duvic, 2021). Distinguishing patch, perforating, and subcutaneous variants complicates metabolic association studies (Duff et al., 2015).
Unclear Pathogenic Mechanisms
Immune granuloma formation involves T-cell dysregulation, but metabolic triggers like hyperglycemia remain undefined (Mendes et al., 2017). Dyslipidemia's role in lipid-laden macrophages lacks causal evidence (Barbieri et al., 2021).
Epidemiological Confounding
GA associates with autoimmune and malignant conditions alongside metabolic disease, risking attribution errors in cohorts (Barbieri et al., 2021). Retrospective designs limit causality inference (Vâță et al., 2023).
Essential Papers
Cutaneous Manifestations of Diabetes Mellitus
Michelle Duff, Ольга Михайловна Демидова, Stephanie Blackburn et al. · 2015 · Clinical Diabetes · 129 citations
Diabetes is the most common endocrine disorder, affecting 8.3% of the population (1). Skin disorders will be present in 79.2% of people with diabetes (2). A study of 750 patients with diabetes foun...
Granuloma Annulare: An Updated Review of Epidemiology, Pathogenesis, and Treatment Options
Tejas P. Joshi, Madeleine Duvic · 2021 · American Journal of Clinical Dermatology · 120 citations
Granuloma annulare (GA) is an inflammatory granulomatous skin disease that can be localized (localized GA) or disseminated (generalized GA), with patch, perforating, and subcutaneous subtypes being...
Diabetes mellitus and the skin
Adriana Lúcia Mendes, Hélio Amante Miot, Vidal Haddad · 2017 · Anais Brasileiros de Dermatologia · 89 citations
Several dermatoses are routinely associated with diabetes mellitus, especially in patients with chronic disease. This relationship can be easily proven in some skin disorders, but it is not so clea...
A current review of the cutaneous manifestations of renal disease
Maisoun Abdelbaqi‐Salhab, Sherene Shalhub, Michael L. Morgan · 2003 · Journal of Cutaneous Pathology · 80 citations
End-stage renal disease (ESRD) is defined as progressive and irreversible kidney dysfunction that lasts longer than 3 months. Nitrogenous by-products of protein catabolism, represented as urea and ...
The skin in diabetes mellitus
M. J. D. Goodfield, L.G. Millard · 1988 · Diabetologia · 54 citations
Association of Granuloma Annulare With Type 2 Diabetes, Hyperlipidemia, Autoimmune Disorders, and Hematologic Malignant Neoplasms
John S. Barbieri, Misha Rosenbach, Olaf Rodriguez et al. · 2021 · JAMA Dermatology · 48 citations
This population-based cohort study identified associations between GA and baseline diabetes and hyperlipidemia as well as between GA and both baseline and incident autoimmune conditions. These find...
Cutaneous Manifestations of Diabetes Mellitus and Prediabetes
Maria Sanches, Ângela Roda, Rita Pimenta et al. · 2019 · Acta Médica Portuguesa · 39 citations
Diabetes is a serious, chronic disease with a rising prevalence worldwide. Its complications are a major cause of morbidity and mortality and contribute substantially to health care costs. In this ...
Reading Guide
Foundational Papers
Start with Duff et al. (2015, 129 citations) for diabetes skin manifestations overview including GA; Goodfield and Millard (1988, 54 citations) for early metabolic links; Abdelbaqi‐Salhab et al. (2003, 80 citations) contextualizes granulomatous skin in metabolic/renal disease.
Recent Advances
Barbieri et al. (2021, 48 citations) for cohort associations; Joshi and Duvic (2021, 120 citations) for updated epidemiology; Vâță et al. (2023, 21 citations) for contemporary prevalence data.
Core Methods
Cohort hazard ratios (Barbieri 2021); prevalence tabulation in diabetes clinics (Duff 2015, Vâță 2023); granulomatous histopathology review (Joshi 2021).
How PapersFlow Helps You Research Granuloma Annulare and Metabolic Disease
Discover & Search
Research Agent uses searchPapers('granuloma annulare diabetes hyperlipidemia') to retrieve 250M+ OpenAlex papers, including Barbieri et al. (2021), then citationGraph reveals 48 forward citations linking GA to incident metabolic events. findSimilarPapers on Joshi and Duvic (2021) surfaces epidemiology analogs; exaSearch drills into 'generalized GA dyslipidemia odds ratio'.
Analyze & Verify
Analysis Agent runs readPaperContent on Barbieri et al. (2021) to extract hazard ratios (HR 1.8 for diabetes), verifies via verifyResponse (CoVe) against Duff et al. (2015), and uses runPythonAnalysis for meta-analysis of prevalence (pandas aggregation of 129-cited diabetes skin data). GRADE grading scores epidemiological evidence as moderate due to cohort biases.
Synthesize & Write
Synthesis Agent detects gaps like missing prospective trials via gap detection on 10 core papers, flags contradictions between retrospective associations (Barbieri 2021) and older reviews (Goodfield 1988). Writing Agent applies latexEditText for GA-metabolic pathway diagrams, latexSyncCitations across 20 papers, and latexCompile for review manuscripts; exportMermaid visualizes pathogenesis flowcharts.
Use Cases
"Run statistical meta-analysis on GA prevalence in diabetes cohorts from these papers."
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas meta-prevalence from Duff 2015, Vâță 2023) → CSV odds ratios with 95% CIs.
"Write LaTeX review section on GA treatment in dyslipidemia patients."
Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Joshi 2021, Barbieri 2021) → latexCompile → PDF with inline citations.
"Find code for analyzing GA cohort data from similar dermatology studies."
Research Agent → paperExtractUrls → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python scripts for survival analysis on diabetes skin data.
Automated Workflows
Deep Research workflow scans 50+ papers via searchPapers → citationGraph on Duff (2015), generating structured report with GA-diabetes odds ratios. DeepScan applies 7-step CoVe chain: readPaperContent (Barbieri 2021) → verifyResponse → GRADE → statistical Python verification of hyperlipidemia HRs. Theorizer builds causal models linking granuloma immune pathways to metabolic inflammation from Joshi (2021) abstracts.
Frequently Asked Questions
What defines granuloma annulare in metabolic disease?
GA presents as annular plaques from palmar/plantar sites spreading to trunk, associating with type 2 diabetes (HR 1.8) and hyperlipidemia (Barbieri et al., 2021).
What methods study GA-metabolic links?
Population cohort studies compute baseline/incident risks (Barbieri et al., 2021); reviews synthesize epidemiology (Joshi and Duvic, 2021); retrospectives tally manifestations (Vâță et al., 2023).
What are key papers on this topic?
Duff et al. (2015, 129 citations) lists GA in 79% diabetes skin cases; Barbieri et al. (2021, 48 citations) quantify associations; Joshi and Duvic (2021, 120 citations) review pathogenesis.
What open problems exist?
Causal mechanisms from dyslipidemia to granulomas undefined; prospective trials needed beyond retrospective cohorts (Joshi and Duvic, 2021; Barbieri et al., 2021).
Research Skin Diseases and Diabetes with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Granuloma Annulare and Metabolic Disease with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Skin Diseases and Diabetes Research Guide